The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapy
2016 ◽
Vol 89
(1059)
◽
pp. 20150963
◽
2018 ◽
Vol 102
(3)
◽
pp. e677
2016 ◽
Vol 96
(2)
◽
pp. E481-E482
2016 ◽
Vol 96
(2)
◽
pp. E607-E608
2019 ◽
Vol 105
(1)
◽
pp. S145-S146
2020 ◽
Vol 108
(3)
◽
pp. e135
2012 ◽
Vol 84
(3)
◽
pp. S556
2019 ◽
Vol 104
(1)
◽
pp. 235
2017 ◽
Vol 99
(2)
◽
pp. S239-S240
2016 ◽
Vol 96
(2)
◽
pp. S174-S175